Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3180 | 1966 | 37.3 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FORMOTEROL | Author keyword | 194 | 54% | 13% | 252 |
2 | SALMETEROL | Author keyword | 168 | 47% | 13% | 264 |
3 | BUDESONIDE FORMOTEROL | Author keyword | 52 | 70% | 2% | 43 |
4 | LEVALBUTEROL | Author keyword | 35 | 67% | 2% | 31 |
5 | S ALBUTEROL | Author keyword | 24 | 91% | 1% | 10 |
6 | LONG ACTING BETA AGONISTS | Author keyword | 22 | 49% | 2% | 32 |
7 | SALMETEROL FLUTICASONE | Author keyword | 19 | 70% | 1% | 16 |
8 | RACEMIC ALBUTEROL | Author keyword | 17 | 79% | 1% | 11 |
9 | SYMBICORT | Author keyword | 15 | 82% | 0% | 9 |
10 | SALBUTAMOL | Author keyword | 15 | 12% | 6% | 112 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FORMOTEROL | 194 | 54% | 13% | 252 | Search FORMOTEROL | Search FORMOTEROL |
2 | SALMETEROL | 168 | 47% | 13% | 264 | Search SALMETEROL | Search SALMETEROL |
3 | BUDESONIDE FORMOTEROL | 52 | 70% | 2% | 43 | Search BUDESONIDE+FORMOTEROL | Search BUDESONIDE+FORMOTEROL |
4 | LEVALBUTEROL | 35 | 67% | 2% | 31 | Search LEVALBUTEROL | Search LEVALBUTEROL |
5 | S ALBUTEROL | 24 | 91% | 1% | 10 | Search S+ALBUTEROL | Search S+ALBUTEROL |
6 | LONG ACTING BETA AGONISTS | 22 | 49% | 2% | 32 | Search LONG+ACTING+BETA+AGONISTS | Search LONG+ACTING+BETA+AGONISTS |
7 | SALMETEROL FLUTICASONE | 19 | 70% | 1% | 16 | Search SALMETEROL+FLUTICASONE | Search SALMETEROL+FLUTICASONE |
8 | RACEMIC ALBUTEROL | 17 | 79% | 1% | 11 | Search RACEMIC+ALBUTEROL | Search RACEMIC+ALBUTEROL |
9 | SYMBICORT | 15 | 82% | 0% | 9 | Search SYMBICORT | Search SYMBICORT |
10 | SALBUTAMOL | 15 | 12% | 6% | 112 | Search SALBUTAMOL | Search SALBUTAMOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SINGLE INHALER | 271 | 82% | 8% | 157 |
2 | FORMOTEROL | 186 | 46% | 15% | 302 |
3 | SALMETEROL | 171 | 29% | 26% | 502 |
4 | INHALED FORMOTEROL | 146 | 82% | 4% | 84 |
5 | SALBUTAMOL | 104 | 23% | 20% | 398 |
6 | BUDESONIDE FORMOTEROL MAINTENANCE | 76 | 93% | 1% | 28 |
7 | PRESCRIBED FENOTEROL | 60 | 49% | 4% | 88 |
8 | RELIEVER THERAPY | 54 | 74% | 2% | 40 |
9 | S ALBUTEROL | 50 | 84% | 1% | 27 |
10 | BETA 2 ADRENOCEPTOR AGONIST | 49 | 56% | 3% | 60 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths | 2006 | 253 | 79 | 72% |
Safety of long-acting beta agonists for the treatment of asthma: clearing the air | 2012 | 23 | 39 | 92% |
Long-Acting beta(2)-Agonist Step-off in Patients With Controlled Asthma Systematic Review With Meta-analysis | 2012 | 21 | 39 | 90% |
Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events | 2008 | 59 | 71 | 79% |
Scientific rationale for inhaled combination therapy with long-acting beta(2)-agonists and corticosteroids | 2002 | 217 | 91 | 60% |
Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma | 2015 | 1 | 34 | 65% |
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children | 2010 | 37 | 243 | 79% |
Scientific rationale for using a single inhaler for asthma control | 2007 | 66 | 73 | 71% |
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review | 2009 | 33 | 86 | 90% |
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events | 2013 | 8 | 127 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIRWAY DIS HEART LUNG | 2 | 67% | 0.1% | 2 |
2 | TEAM PHARMACOEPIDEMIOL PHARMACOECON | 2 | 67% | 0.1% | 2 |
3 | BARLICKI UNIV HOSP | 2 | 18% | 0.5% | 9 |
4 | CLIN UNIT CHILDHOOD ASTHMA | 2 | 43% | 0.2% | 3 |
5 | ABT PNEUMOL IMMUNOL | 1 | 100% | 0.1% | 2 |
6 | PULM ALLERGY ASSOC | 1 | 100% | 0.1% | 2 |
7 | GOTEBORG UNIV | 1 | 33% | 0.2% | 3 |
8 | ASTHMA ALLERGY AIRWAY | 1 | 30% | 0.2% | 3 |
9 | MED EVALUAT UNIT | 1 | 11% | 0.5% | 9 |
10 | LUNG PATHOPHYSIOL | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169211 | CICLESONIDE//INHALED CORTICOSTEROIDS//FLUTICASONE PROPIONATE |
2 | 0.0000133718 | TIOTROPIUM//INDACATEROL//LONG ACTING MUSCARINIC ANTAGONIST |
3 | 0.0000114147 | PROPRANOLOL INDUCED BRONCHOCONSTRICTION//MED FELS CANC MOL BIOL//ALLERGIC BRONCHOCONSTRICTION |
4 | 0.0000109249 | ADRB2//BETA2 ADRENERGIC RECEPTOR//BETA 2 ADRENERGIC RECEPTOR GENE |
5 | 0.0000101450 | BAMBUTEROL//NOCTURNAL ASTHMA//JAMES B SKATRUD PULM SLEEP |
6 | 0.0000098899 | STATUS ASTHMATICUS//ACUTE ASTHMA//ACUTE SEVERE ASTHMA |
7 | 0.0000095628 | JOURNAL OF ASTHMA//ASTHMA CONTROL//ASTHMA EDUCATION |
8 | 0.0000076601 | JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG//NEBULIZER//METERED DOSE INHALER |
9 | 0.0000064593 | INDUCED SPUTUM//SPUTUM CELL COUNTS//SEVERE ASTHMA |
10 | 0.0000063113 | EXERCISE INDUCED ASTHMA//EXERCISE INDUCED BRONCHOCONSTRICTION//EXERCISE INDUCED BRONCHOSPASM |